ABX-CRO
Private Company
Funding information not available
Overview
ABX-CRO is a specialized German CRO with over two decades of experience, focusing on high-complexity areas like radiopharmaceuticals, molecular imaging, and translational medicine in oncology and neuroscience. It has built a global service portfolio through strategic acquisitions and regulatory registrations, recently expanding into the US and India. The company's core value proposition is its ability to navigate the intricate regulatory and technical challenges of imaging-based and radiopharmaceutical drug development from bench to bedside.
Technology Platform
Integrated translational medicine platform specializing in molecular imaging (PET, SPECT, MRI, CT), radiopharmaceutical development (radiolabelling, GMP production, dosimetry), and a global network of preclinical and clinical research partners.
Opportunities
Risk Factors
Competitive Landscape
ABX-CRO competes in a specialized segment of the broader CRO market. It faces competition from large, full-service global CROs (e.g., IQVIA, Parexel) that have imaging divisions, as well as other niche imaging-focused CROs (e.g., BioClinica, now part of Labcorp). Its differentiation lies in its deep, two-decade focus on radiopharmaceuticals and translational imaging in oncology and CNS.